Αποτελέσματα Αναζήτησης
Flibanserin (brand name Addyi) is a treatment currently available in the US for treating female sexual dysfunction - specifically, low sex drive in women. The medication has had mixed reviews so it's unclear exactly how effective this treatment is.
26 Ιαν 2024 · Learn about Vyleesi and Addyi, two medications that can treat female sexual interest/arousal disorder (FSIAD) in premenopausal females. Find out how they work, their side effects, and alternative methods.
17 Μαΐ 2023 · There's no female version of Viagra (a drug that treats ED). Viagra doesn't affect libido and isn't approved for use in women. Addyi and Vyleesi, often called "female Viagra," are approved to treat low libido in women, but they don't affect sexual performance.
Addyi is the first and only FDA-approved pill proven effective for Hypoactive Sexual Desire Disorder (HSDD) in certain premenopausal women. Get started with Addyi today.
18 Δεκ 2015 · Flibanserin (Addyi) is the first oral pill to treat hypoactive sexual desire disorder (HSDD) in premenopausal women. Learn about the diagnosis, etiology, and treatment options for HSDD, including flibanserin, CBT, and sex therapy.
29 Οκτ 2021 · Women whose sex drive needs a boost now have a pill they can take. The first prescription drug to treat low sex drive in women gained FDA (U.S. Food and Drug Administration) approval in August 2015. The drug is flibanserin (Addyi) and it’s a breakthrough for women’s sexual health.
The FDA approved two versions of female Viagra to treat female sexual dysfunction, which are called flibanserin (Addyi) and bremelanotide.
